◀ Back to MAPK12
MAPK12 — ST3GAL4
Text-mined interactions from Literome
Pabbidi et al., Mol Pharmacol 2008
(Hyperalgesia...) :
Furthermore, in stably TRPV1 expressing HEK 293T cells,
STZ treatment
induced an increase in TRPV1 protein content and p-p38
MAPK levels, which was abolished with concomitant treatment with catalase or p38 MAPK inhibitor
Kaur et al., J Invest Dermatol 2010
(Pruritus) :
STZ induced p38 mitogen activated protein kinase ( MAPK ) phosphorylation in mast cells and a pharmacological inhibitor of p38
MAPK , SB203580,
resulted in the attenuation of PGD ( 2 ) levels